Two official information sources are especially useful when considering weight-management treatment in Spain: CIMA explains medicines, while BIFIMED records their public funding status. Keeping those questions separate helps you assess an offer and resolve misunderstandings before visiting a pharmacy.
CIMA for the medicine, BIFIMED for funding
Spain’s medicines agency, AEMPS, provides information through CIMA about authorised products, product documents and supply questions. The Ministry of Health maintains BIFIMED for public funding. An authorised use is therefore not the same as a prescription paid for by the public system.
Ask the practice or pharmacy to identify the product precisely. Useful details include the brand, formulation and national pack code, the Código Nacional. This helps avoid applying information about another strength or presentation to your prescription.
What the October 2026 records show
The Wegovy FlexTouch pack checked under CN 758086 is listed as not funded in BIFIMED. The Mounjaro KwikPen pack checked under CN 764825 is also not funded. The weight-management indications in these entries do not have inclusion in public funding.
For Mounjaro, the checked entry does not confirm funding for the existing adult diabetes indications listed there either. A blanket statement that “insurance pays if you have diabetes” would therefore be misleading. These findings concern the named packs and monthly record; other or new presentations need separate checking.
Clarify what you will actually pay
Request a current price for the exact prescribed pack. Also establish whether consultations, monitoring or additional support will be paid separately. A price for a medicine says nothing by itself about funding the whole course of care.
Record the amount, currency, date and supply period. Do not transfer a price from another country without checking: packs, services and insurance conditions can differ. With private supplementary insurance, you need an answer about your contract; national public classification does not decide every private case.
When the pharmacy does not have the pack
A pack missing from one pharmacy does not automatically mean a nationwide Spanish shortage. The pharmacy can investigate ordering it. Reported supply problems are published through AEMPS and CIMA; entries can change and do not promise stock in a particular branch.
Give the exact presentation whenever you enquire. If your supply is becoming tight, tell the treatment team. Choosing another strength or product, or changing treatment intervals yourself, is not a solution to a supply problem. Have the clinical and practical steps planned together.
Put online offers in context
AEMPS explains that lawful online sales to consumers are restricted to non-prescription medicines supplied by authorised pharmacies. DISTAFARMA helps verify those retailers. An online pharmacy registration therefore does not establish that prescription weight-management medicines can legally be bought from it online.
Be particularly cautious about prescription-free offers, private resale listings and advertising that guarantees results. A photograph, a Spanish-sounding business name or a copied authority logo cannot establish authenticity. Clarify lawful supply through a pharmacy and avoid posting health information in public comment fields.
Common questions
Does a private prescription make the medicine reimbursable?
No. A prescription and a funding decision serve different purposes. Before buying, ask about the exact pack’s status and your insurance arrangements. A privately purchased medicine does not become a publicly funded benefit afterwards simply because a prescription exists.
Are the pack numbers a treatment recommendation?
No. They identify the database records checked so the information can be traced. Product and presentation selection belongs in the medical consultation. Do not use these numbers to order a particular pack without checking your own prescription and the plan agreed with your clinician.
Sources & further reading
- Ministerio de Sanidad: BIFIMED, Wegovy CN 758086, Oktober 2026
- Ministerio de Sanidad: BIFIMED, Mounjaro CN 764825, Oktober 2026
- AEMPS: CIMA Arzneimittelinformation
- AEMPS: Informationen zum Verkauf von Arzneimitteln im Internet
- AEMPS: Lieferprobleme bei Arzneimitteln
Sources checked:
Questions and experiences
Share a question or a useful experience about this topic. Every contribution is checked before publication. Comments may be written in different languages.
Loading reader contributions…
Opening the form sets a necessary session cookie. No email address is required. Publication is subject to moderation and is not guaranteed. For deletion requests: Contact